Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Prophylaxis of DVT with enoxaparin in patients undergoing total knee replacement.

Niazi AU, Umer M, Umar M.

J Pak Med Assoc. 2006 Feb;56(2):72-5.

2.

[Thromboprophylaxis with enoxaparin for total knee replacement: an observational, retrospective and multicentre study comparing starting the treatment before and after the operation].

Llau JV, Gil-Garay E, Castellet E; investigadores del estudio ENOXACOR.

Rev Esp Anestesiol Reanim. 2012 Jun-Jul;59(6):306-14. doi: 10.1016/j.redar.2012.04.016. Epub 2012 Jun 25. Spanish.

PMID:
22738999
3.

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.

Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G; AstraZeneca Arthroplasty Study Group.

Arch Intern Med. 2001 Oct 8;161(18):2215-21.

PMID:
11575978
5.
6.

Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.

Senaran H, Acaroğlu E, Ozdemir HM, Atilla B.

Arch Orthop Trauma Surg. 2006 Jan;126(1):1-5. Epub 2005 Dec 6.

PMID:
16333632
7.

Surveillance venous duplex is not clinically useful after total joint arthroplasty when effective deep venous thrombosis prophylaxis is used.

Schwarcz TH, Matthews MR, Hartford JM, Quick RC, Kwolek CJ, Minion DJ, Endean ED, Mentzer RM.

Ann Vasc Surg. 2004 Mar;18(2):193-8.

PMID:
15253255
8.

Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement.

Özler T, Uluçay Ç, Önal A, Altıntaş F.

Acta Orthop Traumatol Turc. 2015;49(3):255-9. doi: 10.3944/AOTT.2015.14.0219.

9.

Prophylaxis of deep-vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin.

Lastória S, Rollo HA, Yoshida WB, Giannini M, Moura R, Maffei FH.

Acta Cir Bras. 2006 May-Jun;21(3):184-6. Epub 2006 May 26.

10.
11.

Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.

Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM.

Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28. Review.

PMID:
22744711
12.

Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.

Haentjens P, De Groote K, Annemans L.

Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. Epub 2004 Sep 10.

PMID:
15365714
13.

Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.

Wellington K, McClellan K, Jarvis B.

Drugs. 2001;61(8):1185-209. Review.

PMID:
11465877
14.

[Enoxaparin for the prevention of post surgical pulmonary embolism].

Xia XY, Tan YL, Sun YW, Yan GD, Rong YX, Ren QH, Liu JY, Xu XZ, Shan GP, Jin L.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Nov;23(11):661-4. Chinese.

15.

Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial.

McLeod RS, Geerts WH, Sniderman KW, Greenwood C, Gregoire RC, Taylor BM, Silverman RE, Atkinson KG, Burnstein M, Marshall JC, Burul CJ, Anderson DR, Ross T, Wilson SR, Barton P; Canadian Colorectal Surgery DVT Prophylaxis Trial investigators.

Ann Surg. 2001 Mar;233(3):438-44.

16.

The necessity of pharmacological prophylaxis against venous thromboembolism in major joint arthroplasty.

Yassin M, Mitchell C, Diab M, Senior C.

Int Orthop. 2014 May;38(5):1073-5. doi: 10.1007/s00264-013-2233-6. Epub 2013 Dec 19.

17.
18.

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.

Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P; ADVANCE-2 investigators.

Lancet. 2010 Mar 6;375(9717):807-15. doi: 10.1016/S0140-6736(09)62125-5.

PMID:
20206776
19.

The efficacy of a single daily dose of enoxaparin for deep vein thrombosis prophylaxis following total knee arthroplasty.

Pulido PA, Copp SN, Walker RH, Reden LM, Hardwick ME, Colwell CW Jr.

Orthopedics. 2004 Nov;27(11):1185-7.

PMID:
15566131
20.

Supplemental Content

Support Center